Genomic organization and structure of Bruton agammaglobulinemia tyrosine kinase: localization of mutations associated with varied clinical presentations and course in X chromosome-linked agammaglobulinemia.

Míreanna Comhchosúla

• A novel mutation (Cys145-->Stop) in Bruton's tyrosine kinase is associated with newly diagnosed X-linked agammaglobulinemia in a 51-year-old male.
  le: Kornfeld, S. J., et al.
  Foilsithe: (1996)
• X-Linked Agammaglobulinemia Case with TH Domain Missense Mutation in Bruton Tyrosine Kinase
  le: Agrebi, Nourhen, et al.
  Foilsithe: (2021)
• Structural basis for chromosome X-linked agammaglobulinemia: a tyrosine kinase disease.
  le: Vihinen, M, et al.
  Foilsithe: (1994)
• X-chromosome inactivation and mutation pattern in the Bruton's tyrosine kinase gene in patients with X-linked agammaglobulinemia. Italian XLA Collaborative Group.
  le: Moschese, V., et al.
  Foilsithe: (2000)
• Deletion within the Src homology domain 3 of Bruton's tyrosine kinase resulting in X-linked agammaglobulinemia (XLA)
  Foilsithe: (1994)